+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081878
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Automated cell processing systems are redefining cell therapy manufacturing by bringing precision, flexibility, and scalability to workflows that span from laboratory protocols to clinical-scale production. Driven by rapid technology integration, evolving regulations, and strategic industry collaboration, this market is increasingly pivotal for stakeholders aiming to streamline operations and expedite time to clinic while maintaining compliance and quality.

Market Snapshot: Automated Cell Processing Systems

The automated cell processing systems market is characterized by robust adoption across biomanufacturing, driven by advances in robotics, microfluidics, and real-time analytics. As cell therapy pipelines broaden, there is a pronounced need for solutions that reduce human error, increase throughput, and ensure reproducibility. Industry leaders are leveraging modular, closed-system platforms to support clinical and commercial operations, transitioning away from manual and open processes for enhanced regulatory compliance and process standardization.

Scope & Segmentation

  • Component Types: Accessories, consumables including kits, cartridges, reagents (culture media, cytokines, growth factors), a variety of instruments such as cell expansion systems, workstations, selection systems (flow cytometry, magnetic bead, microfluidic), cell washing and concentration systems, service and software offerings.
  • Cell Types: Dendritic cells, NK cells, stem cells, T cells—highlighting further divisions such as CAR-T, TCR-T, and tumor-infiltrating lymphocytes.
  • End Users: Academic and research institutes, contract manufacturing organizations, hospitals and clinics, pharmaceutical and biotechnology companies.
  • Workflow Stages: Cell expansion, selection, cryopreservation and storage, formulation and fill-finish, washing and concentration.
  • Technologies: Closed systems that enhance sterility, open systems allowing flexible protocol customization.
  • Applications: Allogeneic therapy, autologous therapy deployments.
  • Regional Coverage: Detailed analysis spans:
    • Americas: United States (including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies Profiled: Thermo Fisher Scientific Inc., Cytiva US Inc., Sartorius AG, Lonza Group AG, Miltenyi Biotec GmbH, Terumo Corporation, Bio-Techne Corporation, STEMCELL Technologies Inc., Asymptote Ltd., Applikon Biotechnology B.V.

Key Takeaways for Senior Decision-Makers

  • Automated cell processing offers significant gains in operational efficiency by standardizing critical steps, minimizing manual variability, and enabling scalable manufacturing for both autologous and allogeneic therapies.
  • Integration of robotics, advanced analytics, and sensor-driven controls creates adaptive processing environments that enhance monitoring, streamline compliance, and accelerate documentation.
  • Strategic collaborations and cross-industry partnerships, including joint ventures and service-based models, are reshaping competitive dynamics and fostering robust pipelines for new therapies.
  • Development teams benefit from modular system architectures, allowing for rapid protocol reconfiguration and swift adaptation to evolving clinical needs and therapy types.
  • Global supply chain disruptions and changing tariffs are driving a shift toward regional sourcing, on-shore manufacturing, and the adoption of open-architecture platforms, increasing market resilience.
  • Regulatory harmonization and guidance are establishing unified standards, supporting comparability and compliance across regions, and smoothing the path to commercialization.

Tariff Impact: Navigating New Cost Structures and Supply Strategies

Newly imposed United States tariffs on laboratory instruments and reagents, effective from early 2025, are increasing the cost of key components in automated cell processing systems. Manufacturers are facing higher operating expenses and are actively diversifying their supplier networks, pursuing regional sourcing, and forming joint ventures to offset tariff effects. Investments in domestic production facilities for consumables and devices are accelerating, reshaping sourcing strategies and competitive relationships across the global market. These measures are creating greater long-term resilience and supply chain stability, even as near-term volatility persists.

Methodology & Data Sources

Research for this report is grounded in detailed secondary review, including literature, patent filings, and regulatory documents. In-depth primary interviews with sector experts, engineers, and procurement leaders have provided vital insight into current adoption patterns and strategic priorities. Triangulated validation with industry disclosures and financial statements ensures findings are accurate and aligned with real-world industry dynamics.

Why This Report Matters

This report delivers a comprehensive landscape for decision-makers to:

  • Benchmark technology options and business models across segments to guide strategic positioning and investment priorities.
  • Understand the competitive impact of evolving regulations, tariff measures, and regional shifts, supporting risk mitigation and operational flexibility.
  • Access actionable intelligence on emerging innovation, supplier diversification, and commercial partnership opportunities to maximize long-term value.

Conclusion

Automated cell processing systems are fundamentally transforming the cell therapy sector by providing scalable, high-quality, and reproducible manufacturing solutions. Senior stakeholders equipped with the latest market insights will be best positioned to harness technology advancements, optimize operations, and successfully navigate regulatory and trade complexities.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of closed automated bioreactors with real-time AI-driven process analytics for optimized cell yield
5.2. Development of modular automated cell processing platforms enabling rapid scale-up of allogeneic CAR-T manufacturing
5.3. Emergence of disposable single-use cassette systems reducing cross-contamination risks and streamlining validation timelines
5.4. Adoption of fully automated cell washing and concentration systems improving reproducibility in autologous therapies
5.5. Implementation of digital twin modeling in automated cell expansion workflows to predict process outcomes and reduce downtime
5.6. Integration of robotic arms for sample handling and aseptic connectivity in GMP-compliant cell therapy production lines
5.7. Growing partnerships between automation OEMs and contract development manufacturers to provide end-to-end cell therapy solutions
5.8. Introduction of cloud-based process monitoring platforms enabling real-time tracking of critical quality attributes across manufacturing sites
5.9. Regulatory focus on qualification and validation of automated cell processing equipment under updated sterile manufacturing guidelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Cell Processing Systems for Cell Therapy Market, by Component Type
8.1. Introduction
8.2. Accessories
8.3. Consumables
8.3.1. Kits & Cartridges
8.3.2. Reagents
8.3.2.1. Culture Media
8.3.2.2. Cytokines
8.3.2.3. Growth Factors
8.4. Instruments
8.4.1. Cell Expansion Systems
8.4.2. Cell Processing Workstations
8.4.3. Cell Selection Systems
8.4.3.1. Flow Cytometry
8.4.3.2. Magnetic Bead
8.4.3.3. Microfluidic
8.4.4. Cell Washing & Concentration Systems
8.5. Services
8.6. Software
9. Automated Cell Processing Systems for Cell Therapy Market, by Cell Type
9.1. Introduction
9.2. Dendritic Cells
9.3. NK Cells
9.4. Stem Cells
9.5. T Cells
9.5.1. T Cells
9.5.1.1. CAR-T
9.5.1.2. TCR-T
9.5.1.3. Tumor-Infiltrating Lymphocytes
10. Automated Cell Processing Systems for Cell Therapy Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Manufacturing Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotech Companies
11. Automated Cell Processing Systems for Cell Therapy Market, by Workflow Stage
11.1. Introduction
11.2. Cell Expansion
11.3. Cell Selection
11.4. Cryopreservation & Storage
11.5. Formulation & Fill-Finish
11.6. Washing & Concentration
12. Automated Cell Processing Systems for Cell Therapy Market, by Technology
12.1. Introduction
12.2. Closed Systems
12.3. Open Systems
13. Automated Cell Processing Systems for Cell Therapy Market, by Application
13.1. Introduction
13.2. Allogeneic Therapy
13.3. Autologous Therapy
14. Americas Automated Cell Processing Systems for Cell Therapy Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Automated Cell Processing Systems for Cell Therapy Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Cytiva US Inc.
17.3.3. Sartorius AG
17.3.4. Lonza Group AG
17.3.5. Miltenyi Biotec GmbH
17.3.6. Terumo Corporation
17.3.7. Bio-Techne Corporation
17.3.8. STEMCELL Technologies Inc.
17.3.9. Asymptote Ltd.
17.3.10. Applikon Biotechnology B.V.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET: RESEARCHAI
FIGURE 28. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 29. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET: RESEARCHCONTACTS
FIGURE 30. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY KITS & CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY KITS & CARTRIDGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CYTOKINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL EXPANSION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL EXPANSION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL PROCESSING WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL PROCESSING WORKSTATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY MICROFLUIDIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY MICROFLUIDIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL WASHING & CONCENTRATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL WASHING & CONCENTRATION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY NK CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY NK CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CAR-T, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CAR-T, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TCR-T, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TCR-T, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TUMOR-INFILTRATING LYMPHOCYTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TUMOR-INFILTRATING LYMPHOCYTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL EXPANSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CRYOPRESERVATION & STORAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CRYOPRESERVATION & STORAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY FORMULATION & FILL-FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY FORMULATION & FILL-FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WASHING & CONCENTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WASHING & CONCENTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 164. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 165. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 166. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 167. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 170. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 171. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 174. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 175. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 176. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 177. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 180. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 181. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 188. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 189. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL SELECTION SYSTEMS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA AUTOMATED CELL PROCESSING SYSTEMS FOR CELL THERAPY MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Automated Cell Processing Systems for Cell Therapy market report include:
  • Thermo Fisher Scientific Inc.
  • Cytiva US Inc.
  • Sartorius AG
  • Lonza Group AG
  • Miltenyi Biotec GmbH
  • Terumo Corporation
  • Bio-Techne Corporation
  • STEMCELL Technologies Inc.
  • Asymptote Ltd.
  • Applikon Biotechnology B.V.